HİROSHİ OİWA, TORU YAMABE, MASANORİ KAWASHİMA, YUTA MAETANİ, DAİ AGARİ, TAKEMORİ YAMAWAKİ, EİJİ SUGİYAMA
European Journal of Rheumatology - 2017;4(2):148-150
Lupus myelitis (LM) is a rare but serious complication of systemic lupus erythematosus (SLE). In 2009, Birnbaum et al. suggested that LM could be classified into two subtypes, namely gray and white matter myelitis, based on neurological examination findings. Here we describe three cases of this disorder, one with signs of white matter dysfunction and two with signs of gray matter dysfunction. We discuss the potential role of autoantibodies in the development of LM.
